Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Phibro Animal Health ( (PAHC) ) has provided an update.
On December 18, 2025, Phibro Animal Health announced a planned leadership transition effective July 1, 2026, under which long-time Chairman, Chief Executive Officer and President Jack Bendheim will move into the role of Executive Chairman while continuing as Chairman of the Board, and Daniel (Dani) Bendheim will be appointed Chief Executive Officer and President. The move formalizes a generational succession after Jack Bendheim’s decades-long tenure, during which he led significant global expansion and portfolio growth, and maintains continuity as the full executive leadership team remains in place with unanimous board support; Dani Bendheim’s promotion, backed by his extensive operational and strategic experience and involvement in the company’s transformation initiatives, is intended to support Phibro’s long-term growth strategy and reinforce its competitive position in the animal health industry.
The most recent analyst rating on (PAHC) stock is a Hold with a $43.00 price target. To see the full list of analyst forecasts on Phibro Animal Health stock, see the PAHC Stock Forecast page.
Spark’s Take on PAHC Stock
According to Spark, TipRanks’ AI Analyst, PAHC is a Neutral.
Phibro Animal Health’s overall stock score reflects strong financial performance and positive earnings call insights, particularly in the Animal Health segment. However, technical indicators suggest caution, and valuation metrics do not indicate a significant discount. The company’s high leverage and negative cash flow growth are notable risks, but strategic advancements and increased earnings guidance provide a positive outlook.
To see Spark’s full report on PAHC stock, click here.
More about Phibro Animal Health
Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company that provides solutions to livestock producers, farmers, veterinarians and consumers to help maintain and enhance the health of farm and companion animals, positioning itself as a trusted partner across global animal health and nutrition markets.
Average Trading Volume: 287,962
Technical Sentiment Signal: Buy
Current Market Cap: $1.64B
For an in-depth examination of PAHC stock, go to TipRanks’ Overview page.